Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3

Related Experiment Video

Updated: Oct 9, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

S P Tzung1, K M Kim, G Basañez

  • 1Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington, 98195 USA.

Nature Cell Biology
|February 15, 2001
PubMed

Insights

The anti-cancer drug antimycin A targets Bcl-xL proteins, which are involved in cell survival. This study shows antimycin A can directly inhibit Bcl-xL function, offering new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Bcl-2-related proteins regulate cell survival and resistance to various agents.
  • Bcl-xL enhances resistance to tumor necrosis factor and chemotherapy but increases sensitivity to antimycin A.

Purpose of the Study:

  • To investigate the interaction between antimycin A and Bcl-xL.
  • To determine if antimycin A can directly inhibit Bcl-xL function.

Main Methods:

  • Computational molecular docking to predict binding sites.
  • Competitive binding assays with recombinant Bcl-2 and Bak BH3 peptide.
  • Mitochondrial assays measuring swelling and membrane potential (DeltaPsim).
  • Liposome-based assays to assess pore-forming activity.

Main Results:

  • Antimycin A predicted to bind to the BH3-binding groove of Bcl-xL.
  • Antimycin A and Bak BH3 peptide bind competitively to Bcl-2.
  • Both antimycin A and BH3 peptide induce mitochondrial swelling and loss of DeltaPsim in Bcl-xL+ mitochondria.
  • A non-respiratory inhibiting derivative of antimycin A3 retains toxicity for Bcl-xL+ cells and mitochondria.
  • Antimycin A inhibits Bcl-xL pore-forming activity in synthetic liposomes.

Conclusions:

  • Antimycin A directly interacts with and inhibits the function of Bcl-xL.
  • Small molecule ligands can directly target and inhibit Bcl-2 family proteins.
  • Findings suggest novel therapeutic approaches targeting Bcl-xL in cancer treatment.

More Related Videos

Identifying Protein-protein Interaction Sites Using Peptide Arrays07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...